|
Therapeutic Areas
With more than a decade of experience, DP Clinical has established a global organization that has conducted clinical trials in more than 12 therapeutic areas for more than 40 indications. Because of our focus on quality and people, DP Clinical has assembled a dedicated staff with a great deal of experience and very little turn-over. These attributes uniquely position DP Clinical to provide clients the highest-level of service in the most cost-effective way possible.
| Therapeutic Area |
Phase of Clinical Trial |
No. of Sites |
Total Number of Patients |
| Neurological Disorder |
|
|
|
| Acute Spinal Cord Injury |
II – III |
36 |
850 |
| Chronic Spinal Cord Injury |
III |
92 |
590 |
| Diabetic Neuropathy |
II |
8 |
400 |
| Stroke |
II |
18 |
750 |
| Alzheimer’s Disease |
II |
3 |
100 |
| Parkinson’s Disease |
II |
2 |
100 |
| Head Injury |
II |
2 |
80 |
| ALS |
II |
1 |
30 |
| Tardive Dyskinesia |
II |
1 |
25 |
| Multiple Sclerosis |
II |
3 |
30 |
| Hansen’s Disease/Leprosy |
II |
1 |
40 |
| HIV/AIDS |
|
|
|
| Apthous Stomatitis |
II |
16 |
84 |
| Wasting Syndrome |
II |
16 |
45 |
| Cryptosporidiosis/Microsporidiosis |
II |
2 |
50 |
| Infectious Disease (Bactremia, Pneumonia, Skin and Soft Tissue) |
II-III |
65 |
400 |
| Rheumatology/ Bone Disorders |
|
|
|
| Osteoarthritis of the knee |
II-III |
14 |
500 |
| Osteoporosis |
II-III |
3 |
85 |
| Nephrology |
|
|
|
| Chronic Renal Insufficiency |
III |
2 |
40 |
| Oncology |
|
|
|
| Multiple Myeloma |
II |
1 |
100 |
| Hodgkin’s Disease |
II |
2 |
70 |
| Prostate Cancer |
II |
3 |
40 |
| Kaposi’s Sarcoma |
II |
2 |
40 |
| Graft vs. Host |
II |
5 |
50 |
| Malignant Solid Tumor |
II |
2 |
20 |
| MDS |
II |
2 |
50 |
| Ophthalmology |
|
|
|
| Cataract Surgery |
II |
14 |
280 |
| Retinitis Pigmentosa |
II |
2 |
80 |
| Glaucoma |
II, III, IV |
7 |
162 |
| Conjunctivitis |
II-III |
20 |
150 |
| Cardiology |
|
|
|
| CHF |
II – III |
86 |
600 |
| CABG |
II |
1 |
40 |
| HTN |
II |
25 |
500 |
| Pediatric Trials |
|
|
|
| CHF |
II - III |
30 |
160 |
| Hematological |
II – III |
12 |
24 |
| PK Studies |
|
|
|
| Acute Spinal Cord Injury |
II |
10 |
150 |
| Alzheimer’s Disease |
II |
2 |
20 |
| Hanson’s Disease |
II |
2 |
20 |
| IV vs. PO vs. SC routes of administration |
I |
1 |
30 |
| Respiratory Disease |
|
|
|
| Cystic Fibrosis |
II |
2 |
40 |
| Women's Health |
|
|
|
| Device Study |
II |
3 |
180 |
| Blood Disorders |
I |
4 |
16 |
|
|
|
